Proteome-based identification and validation of NXPE3 in childhood acute lymphoblastic leukaemia. | Synapse
April 21, 2026
Proteome-based identification and validation of NXPE3 in childhood acute lymphoblastic leukaemia.
Puntos clave
This research aims to identify NXPE3's potential role as a biomarker in childhood acute lymphoblastic leukaemia (cALL).
Proteome-based identification of NXPE3 in childhood acute lymphoblastic leukaemia.
Assessment of NXPE3's potential in indicating CNS infiltration.
Exploration of NXPE3's role in leukemogenesis.
NXPE3 is identified as a potential biomarker for CNS infiltration in cALL.
Further investigation is suggested to elucidate its role in leukemogenesis.
Resumen
This is the first report of NXPE3 in cALL. NXPE3 was identified as a potential biomarker for assessing CNS infiltration in cALL. Further studies are recommended to explore its role in leukemogenesis.